MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00432-024-05960-7

Медицинская библиотека · Journal of cancer research and clinical oncology · 2024

Association between antithrombotic agents use and hepatocellular carcinoma risk: a two-sample mendelian randomization analysis.

Yang Fengyi, Li Ouyang, Gao Benjian, Chen Zhuo, Li Bo, He Jiaqi, Yang Xiaoli

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Hepatocellular carcinoma (HCC) is the most common primary liver cancer worldwide. Multiple observational studies demonstrated a negative association between the use of antithrombotic agents and the risk of HCC. However, the precise causal relationship between these factors remains uncertain. Therefore, our study used a two-sample Mendelian randomization (MR) analysis to assess the causal link between these two factors.

METHOD: The summary statistics of single nucleotide polymorphisms (SNPs) associated with the use of antithrombotic agents were acquired from a genome-wide association study (GWAS) performed on individuals of European descent. A two-sample MR analysis was performed using the inverse variance weighting (IVW), the weighted median estimate, the MR-Egger regression, and the weighted-mode estimate. Sensitivity analysis of the primary findings was performed using MR-PRESSO, MR-Egger regression, Cochran's Q test, and Leave-one-out analysis.

RESULTS

Ten SNPs associated with the use of antithrombotic agents were selected as instrumental variables. The MR analysis performed using the four methods mentioned above revealed a negative causal association between the use of antithrombotic agents and HCC. Univariate MR estimates based on the inverse variance weighting (IVW) method suggested a negative causal association between the use of antithrombotic agents and HCC [odds ratio (OR) 0.444, 95% confidence interval (CI) 0.279 to 0.707, P = 0.001]. The other methods also produced similar results. No heterogeneity and horizontal pleiotropy were found.

CONCLUSION

Our findings suggested an inverse causal association of antithrombotic agents with the risk of HCC.

Для цитирования: Yang Fengyi, Li Ouyang, Gao Benjian, Chen Zhuo, Li Bo, He Jiaqi, Yang Xiaoli. Association between antithrombotic agents use and hepatocellular carcinoma risk: a two-sample mendelian randomization analysis.. Journal of cancer research and clinical oncology. 2024. DOI: 10.1007/s00432-024-05960-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.